It’s an experiential approach that exposes researchers to the uncertainty and competing perspectives of the medical field, because that’s exactly what they’ll face once the PhD ends.
Most doctoral research starts with a question. Challenge-Based Learning flips that order: it starts with a complex, real-world challenge and builds the research project around it. #ThromboRisk#MSCA
Our doctoral candidates:
🔹 start from a real need in thrombosis research and practice
🔹 engage the relevant stakeholders
🔹 map the clinical, biophysical and societal context
🔹 adapt their questions and methods with supervisors and partners
🎓 Two PhD positions still open at Transilvania University of Brasov within the @ThromboRisk Doctoral Network!
🧠 Multimodal AI Modelling of Thrombosis Data
⚙️ Multi-scale Physics for Thrombus Dynamics
🔗https://t.co/xC4Rv6IsqZ
🔗https://t.co/8mdXBI7PL1
#PhD#MSCA#ThromboRisk
6 July 2026, 2nd Progress Project Meeting. ThromboRisk, #MSCA Doctoral Network, is developing multiscale models – linking cellular, clot and circulation levels – to predict thrombosis risk, supported by AI. Next: our first training school in Maastricht this December. #ThromboRisk
🔬ThromboRisk is live! A European doctoral network, 18 researchers, 6 countries, 4 years, developing predictive models of thrombotic risk from cells to blood flow.
🌐https://t.co/9v1Bj27D6p
#ThromboRisk#MSCA#Thrombosis
The #ThromboRisk consortium has officially launched. On 24 Feb 2026, our Kick-off Meeting brought together leading European entities to advance thrombosis risk modelling and improve cardiovascular care. An exciting journey begins.
#EUResearch#Thrombosis
Our #MSCA Doctoral Network brings together 17 leading entities across Europe to train 18 PhD students in thrombosis research. By integrating laboratory experiments, computer simulations and clinical insights, we aim to develop personalised solutions to save lives. #HorizonEU
We are proud to launch #ThromboRisk, an EU-funded project tackling thrombosis – a cause of one in four deaths worldwide. Using multi-scale models from cells to patients, we aim to revolutionise clot prevention and treatment. #HorizonEU#MSCA#Cardiovascolare